| Name | 8-(2,6-difluorophenyl)-2-(1,3-dihydroxypropan-2-ylamino)-4-(4-fluoro-2-methylphenyl)pyrido[2,3-d]pyrimidin-7-one |
|---|---|
| Synonyms |
Dilmapimod
UNII-Q3238VQW0N SB-681323 |
| Description | Dilmapimod (SB-681323) is a potent p38 MAPK inhibitor that potentially suppresses inflammation in chronic obstructive pulmonary disease. |
|---|---|
| Related Catalog | |
| In Vitro | Dilmapimod (SB-681323) potently inhibits p38 MAPK signaling, measured by inhibition of sorbitol-induced pHSP27 expression[1]. |
| References |
| Molecular Formula | C23H19F3N4O3 |
|---|---|
| Molecular Weight | 456.41700 |
| Exact Mass | 456.14100 |
| PSA | 103.50000 |
| LogP | 2.36040 |